Verona Pharma Plc - ADR
VRNA
Market Cap$7.84B
Close$
$35.33
61.9% downside
Current Fair Value
61.9% downsideOvervalued by 61.9% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $7.84 Billion |
|---|---|
| Enterprise Value | $7.44 Billion |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-2.16 |
| Beta | 0.22 |
| Outstanding Shares | 84,925,625 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -47.74 |
|---|---|
| PEG | 130.09 |
| Price to Sales | 92.7 |
| Price to Book Ratio | 46.35 |
| Enterprise Value to Revenue | 62.81 |
| Enterprise Value to EBIT | -36.97 |
| Enterprise Value to Net Income | -46 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0.05 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Verona Pharma Plc
CEO: David Zaccardelli